- Home
- IH vs TLSA Comparison
IH vs TLSA Comparison
Compare IH & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IH | TLSA |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 200.8M |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IH | TLSA |
|---|---|---|
| Price | $2.14 | $1.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.1K | ★ 285.5K |
| Earning Date | 12-19-2025 | 01-01-0001 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $123,215,612.00 | N/A |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.48 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.55 | $0.63 |
| 52 Week High | $3.60 | $2.60 |
Technical Indicators
Market Signals| Indicator | IH | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 29.62 | 50.49 |
| Support Level | $2.12 | $1.62 |
| Resistance Level | $2.74 | $1.82 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 11.69 | 60.84 |
Price Performance
Historical ComparisonAbout IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.